Search Results

AlloSource®, one of the largest allograft providers creating innovative cellular and tissue products to help surgeons heal their patients, today announced the launch of its AceConnex® Pre-Sutured Fascia device.

AlloSource®, one of the largest allograft providers creating innovative tissue products to help surgeons heal their patients, today announced the first implant of AceConnex Pre-Sutured Fascia device for hip labral reconstruction and augmentation.

AlloSource®, one of the largest nonprofit allograft providers in the U.S. creating innovative cellular and tissue products to help surgeons heal their patients, today announced the launch of AlloMend® Duo Acellular Dermal Matrix (ADM), a natural solution for soft tissue reconstruction.

AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue allografts to help surgeons heal their patients, announced President and CEO, Tom Cycyota, plans to retire.

AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue allografts to help surgeons heal their patients, announced the addition of a quadricep tendon to its AlloConnex™ line of tendons, ligaments and fascia.

AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue allografts to help surgeons heal their patients, today announced the addition of AlloFuse® Micro Fibers Demineralized Bone allograft for use in spinal, foot and ankle or other orthopedic procedures.

AlloSource®, one of the largest allograft providers in the U.S., today announced it was awarded a multi-year contract by the Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response (ASPR) in the Department of Health and Human Services (HHS).

AlloSource®, today announced the launch of AlloMend® Extra-Large (XL) Acellular Dermal Matrix (ADM), the newest addition to the AlloMend product line.

AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products to help surgeons heal their patients, announced it is awarding Dr. David Argo with its fifth annual Dr. Steven Gitelis Inspiration Award.

AlloSource® announced the Journal of Orthopaedic Surgery published the study titled “Short term clinical outcomes of a ProChondrix® thin laser-etched osteochondral allograft for the treatment of articular cartilage defects in the knee.” This study demonstrated encouraging patient-reported outcomes in the treatment of symptomatic articular cartilage lesions using a laser-etched osteochondral allograft, ProChondrix.